Point-of-Care CD4 Testing and ART
Authors found that the point-of-care test performed no worse than lab testing in both pregnant and non-pregnant individuals. This may assist in more quickly identifying those pregnant women needing to start antiretroviral therapy during pregnancy, especially in resource-limited settings.
Citation:
Mnyani CN, McIntyre JA, Myer L. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):260-4.
Abstract
Original Article (subscription may be required)
Citation:
Mnyani CN, McIntyre JA, Myer L. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):260-4.
Abstract
Original Article (subscription may be required)
